+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule



Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule



Federal Register 46(1): 28-30



The Food and Drug Administration(FDA) is amending its patient package insert regulations to make the distribution requirements for patient package inserts for drug products in unit-of-use containers the same as the requirements for products in bulk containers. The agency is also amending its antibiotic drug regulations to permit manufacturers and distributors of antibiotics to make changes in labeling to comply with the patient package insert regulations without advance approval by FDA. This action will conform the requirements for implementing FDA's patient package insert regulations for antibiotics to the requirements currently applicable to the other drugs in the program.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047054140

Download citation: RISBibTeXText

PMID: 10324121


Related references

Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 47(173): 39147-39155, 1982

Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Federal Register 45(179 Pt 2): 60754-60784, 1980

Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Federal Register 46(1): 28-28, 1980

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule. Federal Register 64(232): 67720-67763, 2000

Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Federal Register 64(220): 62110-2, 2000

Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule. Federal Register 65(148): 46864-8, 2000

Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule. Federal Register 73(197): 59496-59501, 2008

The new Food and Drug Administration drug package insert: implications for patient safety and clinical care. Anesthesia and Analgesia 108(1): 211-218, 2009

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 65(168): 52302-5, 2000

Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 64(98): 27666-27693, 1999

Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice. Federal Register 47(173): 39249-39250, 1982

Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule. Federal Register 46(15 Pt 1): 7271-7273, 1981

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record. Federal Register 65(86): 25639-25641, 2000

Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule. Federal Register 72(201): 58993-59000, 2007

Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule. Federal Register 64(19): 4535-4540, 1999